129 related articles for article (PubMed ID: 6127086)
1. Effect of a new potent H2-blocker, 3-[[[2-(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats.
Takeda M; Takagi T; Yashima Y; Maeno H
Arzneimittelforschung; 1982; 32(7):734-7. PubMed ID: 6127086
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
Takagi T; Takeda M; Maeno H
Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
[TBL] [Abstract][Full Text] [Related]
3. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects.
Miwa M; Tani N; Miwa T
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):214-7. PubMed ID: 6325352
[TBL] [Abstract][Full Text] [Related]
5. Effect of a new potent H2-receptor antagonist 3[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2- sulfamoylpropionamidine (YM-11170) on gastric mucosal histamine-sensitive adenylate cyclase from guinea pig.
Harada M; Terai M; Maeno H
Biochem Pharmacol; 1983 May; 32(10):1635-40. PubMed ID: 6134531
[TBL] [Abstract][Full Text] [Related]
6. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
8. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
9. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S
J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
[TBL] [Abstract][Full Text] [Related]
10. Mifentidine: evaluation of antiandrogen effects and kidney function studies.
Francalanza G; Franco C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):456-8. PubMed ID: 2859037
[TBL] [Abstract][Full Text] [Related]
11. Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.
Nielsen ST; Dove PA; Strike DP; Schiehser GA
Drugs Exp Clin Res; 1987; 13(5):297-304. PubMed ID: 2890506
[TBL] [Abstract][Full Text] [Related]
12. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[TBL] [Abstract][Full Text] [Related]
13. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
14. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW
J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583
[TBL] [Abstract][Full Text] [Related]
15. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
[TBL] [Abstract][Full Text] [Related]
16. Effect of the H2-blocker famotidine on gastric mucosal prostaglandin levels in water immersion stress in rats.
Takano K; Sugiyama S; Goto H; Nakazawa S; Ozawa T
Arzneimittelforschung; 1988 Mar; 38(3):364-6. PubMed ID: 2898246
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
Takeda M; Takagi T; Maeno H
Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
[TBL] [Abstract][Full Text] [Related]
18. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
19. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
[TBL] [Abstract][Full Text] [Related]
20. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]